Severity 2 of 5
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Severity 2 (Moderate) recalls cover minor labeling errors, low-risk contamination, and voluntary precautionary recalls. The agency's own classification is typically FDA Class III, or the issue is something like incomplete instructions or a small UPC mismatch where the product itself is safe but doesn't meet documentation requirements. Use the same brand-name product safely; follow the manufacturer's instructions for return or exchange if you want a refund.
The full rubric is on the methodology page. Severity is computed deterministically from the agency’s own classification plus the source text — no editorial vibes.
Aidapak Services, LLC is recalling 100 mg progesterone capsules that may have been mislabeled as ascorbic acid tablets.
Aidapak Services, LLC is recalling 500 mg Ascorbic Acid tablets that may have been mislabeled as Oxcarbazepine 150 mg.
Aidapak Services, LLC is recalling 30 mg Thyroid tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services is recalling 80 mg Atomoxetine capsules distributed in four states because they may be mislabeled as other medications.
Zimmer, Inc. is recalling knee replacement polyethylene inserts to update surgical instructions regarding excessive loading risks.
Aidapak Services, LLC is recalling specific lots of calcium/cholecalciferol/sodium tablets because they may have been mislabeled as other medications.
Aidapak Services, LLC is recalling methylprednisolone tablets that may have been mislabeled as omeprazole/sodium bicarbonate capsules.
Aidapak Services is recalling Simvastatin 40 mg tablets because they may have been mislabeled as Metoprolol Tartrate 12.5 mg.
Aidapak Services is recalling 50 mg Chlorothalidone tablets because they may have been mislabeled as Sennosides 8.6 mg tablets.
Aidapak Services is recalling Estropipate 0.75 mg tablets because they may have been mislabeled as Mesalamine DR 400 mg capsules.
Aidapak Services is recalling Venlafaxine HCL 75 mg tablets because they may have been mislabeled as Tacrolimus capsules.
Aidapak Services is recalling 7,891 sodium chloride tablets that may have been mislabeled as other drugs due to a labeling error.
Aidapak Services is recalling Calcium Acetate tablets that may be mislabeled as Ascorbic Acid or Hyoscyamine Sulfate.
Aidapak Services, LLC is recalling 100 mg HydrOXYzine Pamoate capsules because they may have been mislabeled as other medications.
Aidapak Services, LLC is recalling Disopyramide Phosphate capsules because they may have been mislabeled as Thyroid tablets. The error could lead to patients receiving the wrong medication.
Aidapak Services is recalling 50 mg metoprolol tartrate tablets because they may have been mislabeled as other medications.
Aidapak Services is recalling Carvedilol Phosphate ER capsules due to a potential label mixup with Bumetanide tablets.
Aidapak Services is recalling Lithium Carbonate ER tablets because they may be mislabeled as other medications. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Aspirin EC tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Pregabalin 200 mg capsules because they may have been mislabeled as other prescription drugs.
Siemens is recalling ADVIA 1200 and 1650 chemistry systems because an overflow flag may cause users to misinterpret or edit test results.
Aidapak Services is recalling Levothyroxine Sodium 175 mcg tablets because they may have been mislabeled as Cinacalcet HCl 60 mg.
Aidapak Services, LLC is recalling Isosorbide Dinitrate 5 mg tablets that may have been mislabeled as Cilostazol or Perphenazine.
Aidapak Services, LLC is recalling 1,300 tablets of Glycopyrrolate 2 mg because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Triamterene/Hydrochlorothiazide tablets because they may have been mislabeled as Sevelamer HCl.